ライム病治療の世界市場：2024年～2031年

ライム病治療市場は予測期間中（2024-2031年）にCAGR 8.4%で成長すると予測されます。気候変動、マダニの生息地の拡大、屋外でのレクリエーション活動の増加がライム病を拡大させています。ライム病の罹患率の増加、治療技術の進歩、有利な医療保険政策は、世界のライム病治療市場を牽引する主な要因です。ライム病治療に有効な薬剤を開発するための臨床試験が進行中であることも、市場開発の大きなチャンスとなっています。

市場力学

ライム病患者の発生率と有病率の増加

ライム病は、気候変動が新たな地域への個体群の拡散を促進していることが主な原因となっています。米国保健社会福祉省によると、2023年には米国で年間約47万6,000例のライム病患者が診断・治療されると推定されています。気候変動がマダニの生息地に与える影響により、この細菌感染症の流行は増加すると予想されています。ライム病の診断は、COVIDやME/CFSのような他の疾患と症状が類似しているため困難であり、臨床医は臨床検査と患者の病歴の組み合わせに頼る必要があります。

高まる認識と診断

ライム病に対する人口の増加とヘルスケア臨床の意識の高まりは、正確な診断とワクチン接種のような効果的な治療法の必要性の上昇をもたらしました。例えば、2023年4月、ラトガース大学は、5歳から17歳の小児を対象としたワクチンの有効性を決定することを目的としたライム病ワクチン研究を開始しました。この研究はファイザー社とバルネバ社から委託されたもので、ライム病ワクチンの安全性と有効性を評価することを目的としています。この病気はボレリア・ブルグドルフェリによって引き起こされ、47万6千人のアメリカ人が罹患しています。

さらに2023年5月、州保健環境当局はマダニに咬まれないよう予防を促し、RIDOHはマダニ媒介性疾患に関する新しいデータダッシュボードを立ち上げました。ロードアイランド州保健局とDEMは、マダニに咬まれる厄年を予測し、暖かい気候と発生率の高いライム病により、マダニに咬まれないよう予防策を講じるよう促しています。

市場セグメンテーション

• 投与経路に基づき、市場は経口剤、注射剤、局所剤に区分されます。
• 治療法に基づくと、市場は投薬とダニ駆除に区分されます。
• 販売チャネルに基づき、市場は病院薬局、小売薬局、オンラインに区分されます。

かなりの市場シェアを占める経口サブセグメント

経口薬は摂取が容易であり、治療効率が高いことが、この市場セグメントの成長を牽引する主な要因です。そのため、主なプレーヤーは経口薬の開発に非常に注力しています。例えば、2023年5月、US Biologic社は、米国における主要な媒介感染症であるクロアシダニを標的とした経口ライムワクチンについて、米国農務省の条件付き認可を取得しました。このワクチン「Borrelia Burgdorferi Bacterin」は、マウスのペレットにスプレーコーティングされます。

地域別展望

ライム病治療市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア太平洋地域）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）を含む地域別にさらに細分化されています。

アジア太平洋地域で成長するヘルスケア産業

急速に成長するインドのヘルスケア産業は、ライム病の診断、治療、管理を強化し、施設やサービスへの投資の増加により、新たな健康問題への対応能力を高めています。統計データによると、インドのヘルスケア産業は2016年以降、約22.0%という著しい成長率を遂げています。予測では、2022年までに同産業は3,720億米ドルに達し、収益と雇用の面でインド経済最大のセクターの1つとなります。

北米が主要市場シェアを占める

地域全体におけるライム病の有病率の増加が、この地域のライム病治療市場の需要を牽引する重要な要因です。US News &World Report, L.P.によると、2022年に米国で報告されたライム病患者数は70.0%近く増加しました。保健当局は、この増加は新規感染者の大幅な増加ではなく、報告要件の変更に起因するとしています。米国疾病予防管理センターは、2017年から2019年までの年間平均症例数が約37,000例であったのに対し、2022年には報告症例数が62,000例を超えるとする報告書を発表しました。これらの統計はライム病の全容を把握したものではないことに注意することが重要です。というのも、公式に報告されているのは推定年間症例数476,000件のごく一部に過ぎないからです。

目次

第1章 レポート概要

• 業界の現状分析と成長ポテンシャルの展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主要市場動向
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• AbbVie Inc.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Bayer AG
  • 会社概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• F. Hoffmann-La Roche Ltd.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• ライム病治療の世界市場：投与経路別
  • 経口剤
  • 注射剤
  • 局所
• ライム病治療の世界市場：治療タイプ別
  • 薬物療法
  • ダニ除去
• ライム病治療の世界市場：流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第6章 企業プロファイル

• Almirall, S.A.
• Cipla Ltd.
• Eli Lilly and Co.
• Gilead Sciences, Inc.
• GlaxoSmithKline plc
• Hikma Pharmaceuticals PLC
• Lupin Pharmaceutical, Inc.
• Mayne Pharma Group Ltd.
• Merck & Co., Inc.
• Novartis AG
• Orion Corp.
• Perrigo Company plc
• Pfizer Inc.
• SANOFI S.A.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Bio-Rad Laboratories, Inc.

LIST OF TABLES

• 1. Global Lyme Disease Treatment Market Research And Analysis By Administration Route, 2023-2031 ($ Million)
• 2. Global Oral Lyme Disease Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
• 3. Global Injectable Lyme Disease Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
• 4. Global Topical Lyme Disease Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
• 5. Global Lyme Disease Treatment Market Research And Analysis By Treatment Type 2023-2031 ($ Million)
• 6. Global Medication Lyme Disease Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
• 7. Global Tick Removal Lyme Disease Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
• 8. Global Lyme Disease Treatment Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
• 9. Global Lyme Disease Treatment For Hospital Pharmacies Market Research And Analysis By Region, 2023-2031 ($ Million)
• 10. Global Lyme Disease Treatment For Retail Pharmacies Market Research And Analysis By Region, 2023-2031 ($ Million)
• 11. Global Lyme Disease Treatment For Online Market Research And Analysis By Region, 2023-2031 ($ Million)
• 12. Global Lyme Disease Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
• 13. North American Lyme Disease Treatment Market Research And Analysis By Country, 2023-2031 ($ Million)
• 14. North American Lyme Disease Treatment Market Research And Analysis By Administration Route, 2023-2031 ($ Million)
• 15. North American Lyme Disease Treatment Market Research And Analysis By Treatment Type, 2023-2031 ($ Million)
• 16. North American Lyme Disease Treatment Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
• 17. European Lyme Disease Treatment Market Research And Analysis By Country, 2023-2031 ($ Million)
• 18. European Lyme Disease Treatment Market Research And Analysis By Administration Route, 2023-2031 ($ Million)
• 19. European Lyme Disease Treatment Market Research And Analysis By Treatment Type, 2023-2031 ($ Million)
• 20. European Lyme Disease Treatment Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
• 21. Asia-Pacific Lyme Disease Treatment Market Research And Analysis By Country, 2023-2031 ($ Million)
• 22. Asia-Pacific Lyme Disease Treatment Market Research And Analysis By Administration Route, 2023-2031 ($ Million)
• 23. Asia-Pacific Lyme Disease Treatment Market Research And Analysis By Treatment Type, 2023-2031 ($ Million)
• 24. Asia-Pacific Lyme Disease Treatment Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)
• 25. Rest Of The World Lyme Disease Treatment Market Research And Analysis By Region, 2023-2031 ($ Million)
• 26. Rest Of The World Lyme Disease Treatment Market Research And Analysis By Administration Route, 2023-2031 ($ Million)
• 27. Rest Of The World Lyme Disease Treatment Market Research And Analysis By Treatment Type, 2023-2031 ($ Million)
• 28. Rest Of The World Lyme Disease Treatment Market Research And Analysis By Distribution Channel, 2023-2031 ($ Million)

LIST OF FIGURES

• 1. Global Lyme Disease Treatment Market Share By Treatment Type, 2023 Vs 2031 (%)
• 2. Global Oral Lyme Disease Treatment Market Share By Region, 2023 Vs 2031 (%)
• 3. Global Injectable Lyme Disease Treatment Market Share By Region, 2023 Vs 2031 (%)
• 4. Global Topical Lyme Disease Treatment Market Share By Region, 2023 Vs 2031 (%)
• 5. Global Lyme Disease Treatment Market Share By Treatment Type, 2023 Vs 2031 (%)
• 6. Global Medication Lyme Disease Treatment Market Share By Region, 2023 Vs 2031 (%)
• 7. Global Tick Removal Lyme Disease Treatment Market Share By Region, 2023 Vs 2031 (%)
• 8. Global Lyme Disease Treatment Market Share By Distribution Channel, 2023 Vs 2031 (%)
• 9. Global Lyme Disease Treatment For Hospital Pharmacies Market Share By Region, 2023 Vs 2031 (%)
• 10. Global Lyme Disease Treatment For Retail Pharmacies Market Share By Region, 2023 Vs 2031 (%)
• 11. Global Lyme Disease Treatment For Online Market Share By Region, 2023 Vs 2031 (%)
• 12. Global Lyme Disease Treatment Market Share By Region, 2023 Vs 2031 (%)
• 13. US Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 14. Canada Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 15. UK Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 16. France Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 17. Germany Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 18. Italy Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 19. Spain Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 20. Rest Of Europe Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 21. India Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 22. China Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 23. Japan Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 24. South Korea Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 25. Rest Of Asia-Pacific Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 26. Latin America Lyme Disease Treatment Market Size, 2023-2031 ($ Million)
• 27. Middle East And Africa Lyme Disease Treatment Market Size, 2023-2031 ($ Million)

Lyme Disease Treatment Market Size, Share & Trends Analysis Report by Administration Route (Oral, Injectable, and Topical), by Treatment (Medication, and Tick Removal), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online) Forecast Period (2024-2031)

Lyme disease treatment market is anticipated to grow at a CAGR of 8.4% during the forecast period (2024-2031). Climate change, expanding tick habitats, and increased outdoor recreational activities spread the Lyme disease. The increasing incidence of Lyme disease, advancements in treatment technologies, and favorable medical insurance policies are major factors driving the global Lyme disease treatment market. The ongoing clinical trials to develop an effective drug for Lyme disease treatment offer a huge opportunity for market development.

Market Dynamics

Increasing Incidence and Prevalence of Lyme cases

The globe is experiencing a significant increase in Lyme-related cases, largely owing to climate change, which is facilitating the spread of species populations into new areas. According to the US Department of Health & Human Services, in 2023, there is an estimated annual diagnosis and treatment of approximately 476,000 cases of Lyme disease in the US. The prevalence of this bacterial infection is expected to increase due to the impact of climate change on tick habitats. Diagnosis of Lyme disease can be challenging due to the similarity of symptoms with other illnesses such as COVID and ME/CFS, requiring clinicians to rely on a combination of laboratory tests and patient history.

Growing Awareness and Diagnosis

The growing population and healthcare clinical awareness of Lyme disease have resulted in accurate diagnoses and a rise in the need for effective therapies such as vaccinations. For instance, in April 2023, Rutgers University launched a Lyme Disease Vaccine Study, aiming to determine the efficacy of a vaccine for children aged 5-17. The study, commissioned by Pfizer and Valneva, aims to evaluate the safety and efficacy of a Lyme disease vaccine. The disease, caused by Borrelia burgdorferi, affects 476,000 Americans.

Further, in May 2023, State Health and Environmental Officials urged prevention to prevent tick bites, and RIDOH launched a new data dashboard for tick-borne diseases. The Rhode Island Department of Health and DEM are urging people to take precautions to prevent tick bites owing to warmer weather and high-incidence Lyme disease, predicting a bad year for tick bites.

Market Segmentation

• Based on the administration route, the market is segmented into oral, injectable, and topical.
• Based on treatment, the market is segmented into medication and tick removal.
• Based on the distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online.

Oral Sub-segment to Hold a Considerable Market Share

The easy intake of oral medication and the high efficiency of treatment a major factor driving the growth of this market segment. Therefore, key players are highly focused on the development of oral medications. For instance, in May 2023, US Biologic received USDA Conditional Licensure for its oral Lyme vaccine, which targets the black-legged tick, the leading vector-borne disease in the US. The vaccine, "Borrelia Burgdorferi Bacterin," is spray-coated onto mice's pellets.

Regional Outlook

The Lyme disease treatment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Growing Healthcare Industry in the Asia-Pacific Region

India's rapidly growing healthcare industry is enhancing the diagnosis, treatment, and management of Lyme disease, with increased investment in facilities and services enhancing the country's capability to address new health concerns. According to statistical data, the healthcare industry in India has experienced a significant growth rate of approximately 22.0% since 2016. Projections suggest that by 2022, the industry will have reached a value of $372.0 billion, making it one of the largest sectors in the Indian economy in terms of revenue and employment.

North America Holds Major Market Share

The increasing prevalence of Lyme disease across the region is the key factor driving demand for the regional Lyme disease treatment market. According to the US News & World Report, L.P. in 2022, the number of reported Lyme disease cases in the US increased by nearly 70.0%. Health officials attribute this rise to changes in reporting requirements rather than a significant increase in new infections. The Centers for Disease Control and Prevention released a report stating that the number of reported cases exceeded 62,000 in 2022, compared to an average of about 37,000 cases per year from 2017 to 2019. It is important to note that these statistics do not capture the full extent of Lyme disease, as only a fraction of the estimated 476,000 annual cases are officially reported.

Market Players Outlook

The major companies serving the Lyme disease treatment market include AbbVie Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., and Pfizer Inc. among others. The market players are increasingly focusing on business expansion and product development by applying strategies such as collaborations, mergers and acquisitions to stay competitive in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Market Trends
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. AbbVie Inc.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Bayer AG
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. F. Hoffmann-La Roche Ltd.
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Lyme Disease Treatment Market by Administration Route
  • 4.1.1. Oral
  • 4.1.2. Injectable
  • 4.1.3. Topical
• 4.2. Global Lyme Disease Treatment Market by Treatment Type
  • 4.2.1. Medication
  • 4.2.2. Tick Removal
• 4.3. Global Lyme Disease Treatment Market by Distribution Channel
  • 4.3.1. Hospital Pharmacies
  • 4.3.2. Retail Pharmacies
  • 4.3.3. Online

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World
  • 5.4.1. Latin America
  • 5.4.2. Middle East and Africa

6. Company Profiles

• 6.1. Almirall, S.A.
• 6.2. Cipla Ltd.
• 6.3. Eli Lilly and Co.
• 6.4. Gilead Sciences, Inc.
• 6.5. GlaxoSmithKline plc
• 6.6. Hikma Pharmaceuticals PLC
• 6.7. Lupin Pharmaceutical, Inc.
• 6.8. Mayne Pharma Group Ltd.
• 6.9. Merck & Co., Inc.
• 6.10. Novartis AG
• 6.11. Orion Corp.
• 6.12. Perrigo Company plc
• 6.13. Pfizer Inc.
• 6.14. SANOFI S.A.
• 6.15. Sun Pharmaceutical Industries Ltd.
• 6.16. Teva Pharmaceutical Industries Ltd.
• 6.17. Bio-Rad Laboratories, Inc.